Lee Kirby P, Boyd Elizabeth A, Holroyd-Leduc Jayna M, Bacchetti Peter, Bero Lisa A
University of California, San Francisco, CA, USA.
Med J Aust. 2006 Jun 19;184(12):621-6. doi: 10.5694/j.1326-5377.2006.tb00418.x.
To identify characteristics of submitted manuscripts that are associated with acceptance for publication by major biomedical journals.
DESIGN, SETTING AND PARTICIPANTS: A prospective cohort study of manuscripts reporting original research submitted to three major biomedical journals (BMJ and the Lancet [UK] and Annals of Internal Medicine [USA]) between January and April 2003 and between November 2003 and February 2004. Case reports on single patients were excluded.
Publication outcome, methodological quality, predictors of publication.
Of 1107 manuscripts enrolled in the study, 68 (6%) were accepted, 777 (70%) were rejected outright, and 262 (24%) were rejected after peer review. Higher methodological quality scores were associated with an increased chance of acceptance (odds ratio [OR], 1.39 per 0.1 point increase in quality score; 95% CI, 1.16-1.67; P < 0.001), after controlling for study design and journal. In a multivariate logistic regression model, manuscripts were more likely to be published if they reported a randomised controlled trial (RCT) (OR, 2.40; 95% CI, 1.21-4.80); used descriptive or qualitative analytical methods (OR, 2.85; 95% CI, 1.51-5.37); disclosed any funding source (OR, 1.90; 95% CI, 1.01-3.60); or had a corresponding author living in the same country as that of the publishing journal (OR, 1.99; 95% CI, 1.14-3.46). There was a non-significant trend towards manuscripts with larger sample size (>/= 73) being published (OR, 2.01; 95% CI, 0.94-4.32). After adjustment for other study characteristics, having statistically significant results did not improve the chance of a study being published (OR, 0.83; 95% CI, 0.34-1.96).
Submitted manuscripts are more likely to be published if they have high methodological quality, RCT study design, descriptive or qualitative analytical methods and disclosure of any funding source, and if the corresponding author lives in the same country as that of the publishing journal. Larger sample size may also increase the chance of acceptance for publication.
确定提交给主要生物医学期刊并被接受发表的稿件的特征。
设计、背景与参与者:一项前瞻性队列研究,研究对象为2003年1月至4月以及2003年11月至2004年2月期间提交给三本主要生物医学期刊(《英国医学杂志》《柳叶刀》[英国]和《内科学年鉴》[美国])的报告原创研究的稿件。排除关于单个患者的病例报告。
发表结果、方法学质量、发表的预测因素。
在该研究纳入的1107篇稿件中,68篇(6%)被接受,777篇(70%)被直接拒绝,262篇(24%)在同行评审后被拒绝。在控制研究设计和期刊因素后,较高的方法学质量得分与被接受的可能性增加相关(质量得分每增加0.1分,优势比[OR]为1.39;95%置信区间[CI]为1.16 - 1.67;P < 0.001)。在多变量逻辑回归模型中,如果稿件报告了随机对照试验(RCT)(OR为2.40;95%CI为1.21 - 4.80);使用描述性或定性分析方法(OR为2.85;95%CI为1.51 - 5.37);披露任何资金来源(OR为1.90;95%CI为1.01 - 3.60);或者通讯作者与发表期刊所在国家相同(OR为1.99;95%CI为1.14 - 3.46),则这些稿件更有可能被发表。样本量较大(≥73)的稿件有被发表的非显著趋势(OR为2.01;95%CI为0.94 - 4.32)。在调整其他研究特征后,具有统计学显著结果并不能提高研究被发表的可能性(OR为0.83;95%CI为0.34 - 1.96)。
如果提交的稿件具有较高的方法学质量、RCT研究设计、描述性或定性分析方法以及披露任何资金来源,并且通讯作者与发表期刊所在国家相同,那么这些稿件更有可能被发表。较大的样本量也可能增加被接受发表的机会。